22834-71-5

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 7045-40-1 Methyl 3,5-O-Isopropylidene-α-D-xylofuranoside 
• 551929-55-6 methyl-[O³,O⁵-isopropylidene-O²-(toluene-4-sulfonyl)-α-D-xylofuranoside] 

Downstream Products

• 96622-59-2 Methyl-5-O-benzoyl-2-O-tosyl-α-D-xylofuranosid 
• 126716-27-6 methyl 2,5-di-O-benzoyl-3-fluoro-3-deoxy-α-D-ribofuranoside 
• 123484-12-8 ((2R,3R,4S)-5-acetoxy-4-(benzoyloxy)-3-fluorotetrahydrofuran-2-yl)methyl benzoate 
• 237410-13-8 ((2R,3S,4S,5S)-3-fluoro-4-hydroxy-5-methoxytetrahydrofuran-2-yl)methyl benzoate 
• 551929-57-8 Toluene-4-sulfonic acid (2S,3R,4R,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-4-fluoro-2-methoxy-tetrahydro-furan-3-yl ester 
• 122654-35-7 C₂₄H₁₇Cl₂FN₄O₅ 
• 551929-59-0 C₃₁H₂₄ClFIN₅O₅ 
• 96639-62-2 Methyl-5-O-benzoyl-2-O-tosyl-α-D-erythro-pentofuranosid-3-ulose 
• 66108-03-0 methyl 2,3-anhydro-5-O-toluenesulfonyl-α-D-lyxofuranoside 

Relevant academic research and scientific papers

Design and synthesis of A3 adenosine receptor ligands, 3′-fluoro analogues of Cl-IB-MECA

Synthesis of 3′-deoxy-3′-fluoro-N6-substituted adenosines as bioisosteres of Cl-IB-MECA and their binding affinities to A 3 adenosine receptor are described.

NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT

The invention provides unsaturated phosphonates of Formula I or a tautomer or pharmaceutically accepatble salt thereof, as described herein, as well as pharmaceutical compositions comprising the compounds, and therapeutic methods comprising administering the compounds. The compounds have anti-viral properties and are useful for treating viral infections (e.g. HCV) in animals (e.g. humans).